Difference between revisions of "Team:Kent/Team"

Moyra Chikomo

Moyra is an Electronics and Communications student in her 2nd year at the University of Kent.

Raneem Jaghoub

Raneem is an Electronics and Communications student in her 1st year at the University of Kent.

Jonathan Pope

Jonathan is a Biology student in his 2nd year at the University of Kent.

Rob Middlewick

Rob is a Biology student in his 2nd year at the University of Kent.

Richard Crane

Richard is a Biomedical Science student in his 2nd year at the University of Kent.

James Aston

James is a student in the School of Physical Sciences. He worked on the modelling and the wiki.

Katarina Pisani

Katarina is a Biomedical Science student in her 2nd year at the University of Kent.

Anna Beltrami

Anna is a Biomedical Science student in her 2nd year at the University of Kent.

Suparna Thakali

Suparna is a Biochemistry student in her 2nd year at the University of Kent.

Natalie Sloan

Natalie is a Biomedical Science student in her 2nd year at the University of Kent.

Alice Tomlinson

Alice is a Biomedical Science student in her 2nd year at the University of Kent.

Ben Blakeman

Ben

Morena

Morena

Dr Wei-Feng Xue

Dr Wei-Feng Xue joined the school of Biosciences in 2011 as Lecturer in Chemical biology, and he is now Senior Lecturer in Chemical biology since 2014. He received his PhD degree in Physical Chemistry on research regarding protein-protein/protein-ligand interactions in Prof. Sara Linse’s group at Lund University in Sweden (2006). He then went on to do postdoctoral research concerning the mechanism and the biological impact of amyloid assembly in Prof. Sheena Radford’s laboratory at the Astbury Centre for Structural Molecular Biology in the University of Leeds (2006-2011). His research interests include supramolecular protein assembly, protein folding and misfolding, amyloid and prions, and AFM imaging.

Wei-Feng is a member of the Kent Fungal Group, the Protein Form and Function Group and the Centre for Molecular Processing

Dr Mark Shepherd

Dr Mark Shepherd joined the School of Biosciences in 2011. He was born in England, was brought up in North Wales, and subsequently studied Biochemistry at the University of Sheffield (1996-1999). He stayed in the Department of Molecular Biology & Biotechnology to undertake a PhD with Professor Neil Hunter FRS (1999-2003), where he developed his interest in the enzymology and spectroscopy of chlorophyll and haem biosynthesis. After completing his PhD studies, he conducted postdoctoral research with Prof. Harry Dailey at the University of Georgia (2003-2005), where his research focussed on the terminal enzymes of haem biosynthesis. This was followed by a move back to the University of Sheffield in 2005 to take up a postdoctoral position with Prof. Robert Poole, where he developed interests in E. coli respiration, globin proteins, and the response of bacteria to nitric oxide. A subsequent position at the University of Queensland (2010-2011) with Prof. Mark Schembri focussed on nitric oxide stress in Uropathogenic E. coli.

In 2011 Mark moved to the University of Kent, where he is a Lecturer in Microbial Biochemistry and a member of the Microbial Pathogenesis Group.

Luca

Dr Mark Wass

Mark joined the School of Biosciences in October 2012. He obtained his first degree in Natural Sciences at Cambridge University in 2000 followed by a Masters in Computing at Imperial College London. After a few years working in Industry as an IT consultant Mark studied for a PhD with Prof Mike Sternberg at Imperial (2004-2008) and continued onto a post-doctoral position in the group until 2011. In 2011 Mark was awarded a FEBS Long Term Fellowship to work in the group of Alfonso Valencia at the CNIO (Spanish National Cancer Research Centre, Madrid, Spain).
Mark's research interests are in Structural Bioinformatics particularly the analysis and prediction of protein function, structure and interactions. He is also interested in using such approaches to analyse genetic variation and identify the functional effects that are associated with disease.
Mark is a member of the Cytogenomics and Bioinformatics Group.